These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 975814)

  • 1. Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel.
    Weiner E; Johansson ED
    Contraception; 1976 Jul; 14(1):81-92. PubMed ID: 975814
    [No Abstract]   [Full Text] [Related]  

  • 2. Contraception with d-norgestrel silastic rods. Plasma levels of d-norgestrel and influence on the ovarian function.
    Weiner E; Johansson ED
    Contraception; 1976 Nov; 14(5):551-62. PubMed ID: 987891
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles.
    Victor A; Johansson ED
    Contraception; 1976 Aug; 14(2):215-26. PubMed ID: 949897
    [No Abstract]   [Full Text] [Related]  

  • 4. A D-norgestrel-releasing IUD.
    Nilsson CG; Johansson ED; Luukkainen T
    Contraception; 1976 Apr; 13(4):503-14. PubMed ID: 1253602
    [No Abstract]   [Full Text] [Related]  

  • 5. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.
    Moore DE; Roy S; Stanczyk FZ; Mishell DR
    Contraception; 1978 Apr; 17(4):315-28. PubMed ID: 648154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
    Mishell DR; Moore DE; Roy S; Brenner PF; Page MA
    Am J Obstet Gynecol; 1978 Jan; 130(1):55-62. PubMed ID: 619648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New combined oral contraceptive with incremental progestogen dosage regimen.
    Brosens I; Van Assche A; Koninckx P; Heyns W; De Hertogh R
    Eur J Obstet Gynecol Reprod Biol; 1976; 6(6):315-8. PubMed ID: 1035172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical assessment of subdermal implants of megestrol acetate, d-norgestrel, and norethindrone as a longterm contraceptive in women.
    Croxatto HB; Díaz S; Quinteros E; Simoneti L; Kaplan E; Rencoret R; Leixelard P; Mártinez C
    Contraception; 1975 Dec; 12(6):615-27. PubMed ID: 1204349
    [No Abstract]   [Full Text] [Related]  

  • 9. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
    Alvarez F; Faundes A; Johansson E; Coutinho E
    Fertil Steril; 1983 Jul; 40(1):120-3. PubMed ID: 6407876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraception with megestrol acetate implants. Megestrol acetate levels in plasma and the influence on the ovarian function.
    Weiner E; Johansson ED
    Contraception; 1976 Jun; 13(6):685-95. PubMed ID: 1277840
    [No Abstract]   [Full Text] [Related]  

  • 13. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
    Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
    Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function.
    Lähteenmäki P
    Acta Obstet Gynecol Scand Suppl; 1978; 76():1-43. PubMed ID: 696249
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of norethindrone and some other synthetic gestagens upon the peripheral plasma levels of progesterone and estradiol during early, human pregnancy.
    Nygren KG; Johansson ED
    Acta Obstet Gynecol Scand; 1975; 54(1):57-63. PubMed ID: 46683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary and gonadal function during the use of norgestrelestradiol vaginal rings.
    Toivonen J; Lähteenmäki P; Luukkainen T
    Contraception; 1978 Sep; 18(3):201-11. PubMed ID: 720065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral plasma levels of d-norgestrel in women after oral administration of d-norgestrel and when using intravaginal rings impregnated with dl-norgestrel.
    Victor A; Edqvist LE; Lindberg P; Elamsson K; Johansson ED
    Contraception; 1975 Sep; 12(3):261-78. PubMed ID: 1164846
    [No Abstract]   [Full Text] [Related]  

  • 18. Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review.
    Korba VD; Heil CG
    Fertil Steril; 1975 Oct; 26(10):973-81. PubMed ID: 1183625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-norgestrel: an estrogen-free, cyclic oral contraceptive.
    Cohen MR; Lieberman JS
    J Reprod Med; 1976 Aug; 17(2):125-30. PubMed ID: 957362
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rigevidon and Ovidon in the therapy of menstrual cycle disorders].
    Prilepskaia VN; Baklaenko NG; Chernaia VV
    Akush Ginekol (Mosk); 1983 Nov; (11):24-7. PubMed ID: 6666792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.